REPORT HIGHLIGHT
Self-Injection Devices Market size was valued at USD 7,541.9 Million in 2022, expanding at a CAGR of 8.7% from 2023 to 2030.
Self-injection devices are medical devices designed to allow individuals to administer medications or therapeutic substances to themselves. These devices are particularly beneficial for patients with chronic conditions that require regular injections, such as diabetes, rheumatoid arthritis, multiple sclerosis, and various other diseases.
Self-Injection Devices Market- Market Dynamics
Increasing number of regulatory approvals, and the user-friendly benefits to propel market demand
The growing preference for self-administration of medications, an increasing number of regulatory approvals, and the user-friendly benefits are expected to drive market growth. Government backing, favorable reimbursement policies, and technological advancements in self-injection devices stand out as major factors poised to boost the market. Needlestick injuries resulting from contaminated needles represent a primary concern for healthcare providers, as they pose a significant risk. Injections, being a common method for drug administration, put healthcare workers at a heightened risk of accidental exposure to blood-borne pathogens. Consequently, the rising incidents of needlestick injuries are projected to boost the demand for self-injection devices in the foreseeable future. Self-injection technologies offer faster drug delivery and improved dosage consistency compared to invasive methods. These devices reduce the required drug dosage, enhancing patient compliance, especially among older patients. Needle-free injectors like jet injectors are effective, convenient, reduce hospital stays and overall healthcare costs, promote patient compliance, and are well-suited for home care settings. As a result, the increasing advantages associated with self-injection devices are expected to foster overall market growth.
Self-Injection Devices Market- Key Insights
- As per the analysis shared by our research analyst, the global Self-Injection Devices market is estimated to grow annually at a CAGR of around 8.7% over the forecast period (2023-2030)
- The Self-Injection Devices market is projected to grow at a significant rate due to increasing number of regulatory approvals, and the user-friendly benefits
- Based on type segmentation, Pen Injectors segment was predicted to show maximum market share in the year 2022
- Based on Usability segmentation, disposable segment is expected to witness the fastest growth
- On the basis of region, North America was the leading revenue generator in 2022
Self-Injection Devices Market- Segmentation Analysis:
The Global Self-Injection Devices Market is segmented on the basis of Usability, Type, Application, and Region.
The market is divided into two categories based on Usability: Disposable and Reusable. In 2022, the disposable segment dominated with the largest revenue share. Growing concerns regarding the risks associated with needlestick injuries and increasing awareness of the advantages offered by disposable self-injection devices have spurred rapid market growth. These devices are especially convenient for frequent, low-volume injections or variable dosing regimens.
The market is divided into four categories based on type: Autoinjectors, Pen Injectors, Wearable Injectors and Needle-free Injectors. The pen injectors segment, with its exceptional efficiency and global adoption, secured the largest revenue share in 2022. Pen injectors, highly advanced syringes, are designed for precise and dependable administration of biotech substances like human growth hormone and insulin. The evolution of pen injectors has significantly enhanced drug delivery convenience for patients, leading to a surge in demand throughout the projected period. The increasing prevalence of acute and chronic diseases has heightened awareness about the significance of pen injectors, especially in emerging countries.
Self-Injection Devices Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Self-Injection Devices Market- Competitive Landscape:
Companies in the Self-Injection Devices Market implement several strategies to remain competitive and address the evolving needs of users. These strategies include product innovation, where companies continuously develop user-friendly and technologically advanced self-injection devices, such as smart injection pens and auto-injectors. They also focus on partnerships and collaborations with pharmaceutical companies to ensure compatibility with various medications, expanding their market reach. Additionally, companies emphasize patient education and support programs to assist users in using these devices effectively and safely. Regulatory compliance and adherence to quality standards are paramount to gain trust in the healthcare industry. Overall, a patient-centric approach and a commitment to improving the patient experience are central to their strategies.
Recent Developments:
In October 2021, Ypsomed introduced the world's first autoinjector featuring integrated connectivity. This innovation links the SmartPilot, a interacted reusable addon, to the YpsoMate autoinjector, seamlessly integrating the auto-injector into a alphanumeric therapy management classification.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL SELF-INJECTION DEVICES MARKET KEY PLAYERS
- Ypsomed AG
- BD
- Gerresheimer AG
- Antares Pharma
- Haselmeier AG
- NuGen Medical Devices
- Owen Mumford Ltd
- SHL Medical AG
- Pfizer, Inc.
- Amgen
GLOBAL SELF-INJECTION DEVICES MARKET, BY USABILITY
GLOBAL SELF-INJECTION DEVICES MARKET, BY TYPE
- Autoinjectors
- Pen Injectors
- Wearable Injectors
- Needle-free Injectors
GLOBAL SELF-INJECTION DEVICES MARKET, BY APPLICATION
- Cancer
- Autoimmune Disorders
- Hormonal Disorders
- Pain Management
- Others
GLOBAL SELF-INJECTION DEVICES MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA